Olive oil and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Olive oil (olive), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Carboplatin, and have Lung cancer - non-small cell.

The study is created by eHealthMe based on reports of 431 people who have side effects when taking Olive oil from the FDA, and is updated regularly.

What is Olive oil?

Olive oil has active ingredients of olive. eHealthMe is studying from 436 Olive oil users. Check the latest studies of Olive oil.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 04, 2026

431 people reported to have side effects when taking Olive oil.
Among them, 12 people (2.78%) died.

Among these 12 people:

How long have people been on Olive oil when they died? *

What is the gender of people who died when taking Olive oil? *

female: 70 %
male: 30 %

What is the age of people who died when taking Olive oil? *

What are other drugs people take besides Olive oil? *

What are other side effects people have before they died? *

Rashes (redness): 3 people, 25.00%
Fatigue (feeling of tiredness): 3 people, 25.00%
Hepatitis (inflammation of the liver): 2 people, 16.67%
Constipation: 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Abdominal Discomfort: 2 people, 16.67%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 1 person, 8.33%
Generalised Erythema (redness of the skin all over the body): 1 person, 8.33%
Fever: 1 person, 8.33%
Retching (strong involuntary effort to vomit): 1 person, 8.33%

What are the existing conditions these people have? *

Lung Cancer - Non-Small Cell (lung cancer): 4 people, 33.33%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 2 people, 16.67%
Neoplasm Malignant (cancer tumour): 2 people, 16.67%
Adverse Event: 2 people, 16.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Malignant Respiratory Tract Neoplasm (cancer tumour of respiratory tract): 1 person, 8.33%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Gastrointestinal Carcinoma (cancer of stomach or intestine): 1 person, 8.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Olive oil:

Olive oil (436 reports)

Expand to all the drugs that have ingredients of olive:

Death and drugs with ingredients of olive

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Olive oil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,107 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on olive (the active ingredients of Olive oil) and Olive oil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.